Experimental Validation of the Docking Orientation of Cdc25 with Its Cdk2-CycA Protein Substrate.
Sohn, J., Parks, J.M., Buhrman, G., Brown, P., Safi, A., Edelsbrunner, H., Yang, W., Rudolph, J.(2005) Biochemistry 44: 16563-16573
- PubMed: 16342947 
- DOI: 10.1021/bi0516879
- Primary Citation of Related Structures:  
2A2K - PubMed Abstract: 
Cdc25 phosphatases are key activators of the eukaryotic cell cycle and compelling anticancer targets because their overexpression has been associated with numerous cancers. However, drug discovery targeting these phosphatases has been hampered by the lack of structural information about how Cdc25s interact with their native protein substrates, the cyclin-dependent kinases ...